Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Mattson Technology, Inc. (NASDAQ: MTSN) shares declined 1.49 percent to close at $2.64 a share Friday. The stock traded between $2.64 and $2.84 on volume 1.97 million shares traded. Analysts at Cowen have recently initiated coverage on the company with an "outperform" rating and a price target of $4.00. Shares of Mattson Technology have fallen approximately 4.0 percent year-to-date.
Find out more about Mattson Technology including full access to the free equity report at:
www.RDInvesting.com/MTSN
Textron Inc. (NYSE: TXT) shares declined 0.57 percent to close at $38.31 a share Friday. The stock traded between $38.03 and $38.54 on volume of 4.0 million shares traded. Analysts at Nomura have recently initiated coverage on the company with a "neutral" rating and a price target of $41.00. Shares of Textron have gained approximately 4.0 percent year-to-date.
Find out more about Textron including full access to the free equity report at:
www.RDInvesting.com/TXT
XenoPort, Inc. (NASDAQ: XNPT) shares gained 2.21 percent to close at $6.02 a share Friday. The stock traded between $5.75 and $6.19 on volume of 1.33 million shares traded. Analysts at Credit Suisse have recently initiated coverage on the company with an "outperform" rating and a price target of $7.00. Shares of XenoPort have gained approximately 5.0 percent year-to-date.
Find out more about XenoPort including full access to the free equity report at:
www.RDInvesting.com/XNPT
Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) shares increased 10.24 percent to close at $20.88 a share Friday. The stock traded between $19.34 and $21.24 on volume of 840,394 shares traded. Analysts at Leerink have recently initiated coverage on the company with an "outperform" rating and a price target of $26.00. Shares of Zeltiq Aesthetics have gained approximately 10.0 percent year-to-date.
Find out more about Zeltiq Aesthetics including full access to the free equity report at:
www.RDInvesting.com/ZLTQ
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]